Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAPsychiatric nurse practitioner Rebecca Jollotta testified in Lindsay Clancy's murder trial this week, describing months of messages, medication changes and a bipolar disorder concern she raised while treating Clancy in late 2022.
A psychiatric nurse practitioner who treated Lindsay Clancy testified this week about the medications, messages and appointments that shaped her care in the two months before Clancy killed her three young children in Duxbury, Massachusetts.
Rebecca Jollotta, who began treating Clancy in late November 2022 through a perinatal behavioral health program, told jurors that Clancy repeatedly sought changes to her medication plan, describing intrusive thoughts, insomnia and numbness she attributed to the drugs. Clancy, now 36, has pleaded not guilty to three counts of murder in the deaths of her 5-year-old daughter, 3-year-old son and infant son on Jan. 24, 2023. Her attorneys have said she does not dispute killing the children but argue she was suffering from postpartum psychosis and bipolar disorder and should not be held criminally responsible.
According to testimony, Clancy messaged Jollotta on Dec. 3, 2022, describing "horrible intrusive thoughts" and a deeply depressed mood, and reported that taking Ativan improved her symptoms. At an in-person appointment on Dec. 6, attended by both Clancy and her husband, Jollotta noted an anxious mood but described Clancy's thought process as linear and goal-directed, with no signs of hallucinations, delusions, psychosis, mania, or suicidal or homicidal intent recorded that day. Jollotta testified she raised concerns at that meeting about a possible underlying bipolar disorder.
By Dec. 12, Jollotta said she "strongly" recommended Clancy enter a partial hospitalization program. Three days later, Clancy reported persistent suicidal thoughts and went to the emergency room at a Boston hospital, according to testimony. On Dec. 16, Clancy agreed to enter a partial hospitalization program at a Rhode Island hospital, and Jollotta recommended increasing one medication's dosage while continuing another nightly, along with discussing a mood stabilizer that Clancy's psychiatrist had also proposed.
Jollotta's last contact with Clancy was Dec. 21, 2022, roughly a month before the killings. Under cross-examination, defense attorneys asked whether Jollotta was aware that the Rhode Island hospital had declined to admit Clancy to its program over concerns she had been overmedicated, and that a doctor there had attributed her depressive symptoms to adverse drug effects rather than an underlying psychiatric illness. Jollotta testified she was not aware of that assessment.
Testimony also touched on a period around Dec. 30, when Clancy's husband contacted Jollotta about seeking a higher level of care for his wife. Jollotta told jurors she provided guidance and tapering instructions when Clancy traveled during the holidays and said she was not informed of any problems with the taper at that time.
Jollotta is one of several mental health providers called to testify as the trial moves through its third week, following earlier testimony from Clancy's psychiatrist, who prescribed roughly half of the approximately 30 medications Clancy received during her treatment.
Prosecutors have argued Clancy acted "intentionally, rationally and swiftly" and have pointed to her efforts to change treatment plans as evidence she understood her actions. The defense has used testimony from Clancy's care providers to argue that her medication history and worsening symptoms in the weeks before the killings support a psychosis-based defense and has questioned whether providers fully accounted for the effects of frequent medication changes on her condition.
Jollotta's testimony is central to establishing Clancy's documented mental state and treatment history in the weeks leading up to the deaths, evidence both sides are using to support opposing arguments about her criminal responsibility. The case has also drawn attention to how postpartum mental health conditions are treated and monitored in clinical settings.
Testimony from additional medical providers who treated Clancy is expected to continue as the trial proceeds in Plymouth Superior Court. The case will ultimately turn on whether jurors find Clancy legally responsible for her actions or accept the defense's argument that she was experiencing postpartum psychosis at the time of the killings.